Structural integrity. Functional recovery. Scientific validation.
Cryopreservation That Preserves Function
Derived from Japanese PROTON Magnetic Freezing Technology, Proton CryoTech applies controlled structural ice modulation to support biological architecture and post-thaw functional stability.
In advanced therapies…
Structural integrity
Designed for 3D cellular systems (organoids, spheres)
Functional recovery
Focus on markers, secretion, electrophysiology
Operational practicality
Reduced dependency on LN₂ handling workflows
A New Standard in Cryopreservation
PROTON reframes freezing as molecular engineering: a controlled phase transition that protects the ultra‑structure of living systems.
Uniform nucleation
Promotes spatially distributed nucleation to reduce uncontrolled crystal growth and localized mechanical stress.
Reduced osmotic shock
More homogeneous phase transition can reduce extreme solute concentration gradients and dehydration stress.
Structural cryopreservation
Engineered for complex 3D cellular systems where diffusion limits and thermal gradients challenge structural preservation.
THE CRITICAL MOMENT - Ice Crystallization
During cryopreservation, the defining event is not storage temperature but phase transition.
As water forms ice, crystallization dynamics determine structural stress within biological systems. Uncontrolled intracellular and extracellular crystal expansion may disrupt membrane integrity, alter intracellular organization, and compromise long-term biological performance.
The quality of preservation is defined at the moment of crystallization.
When Cellular Architecture Is Disrupted
Mechanical stress generated during uncontrolled freezing can affect:
• Membrane structure
• Organelle organization
• Cytoskeletal stability
• Intracellular signaling pathways
• Functional differentiation capacity
Post-thaw viability metrics alone do not necessarily reflect functional preservation.
Introducing Structural Ice Control
Derived from Japanese PROTON Magnetic Freezing Technology, Proton CryoTech integrates controlled electromagnetic fields during freezing to influence nucleation behavior and crystallization dynamics.
This structural modulation supports preservation of biological architecture and functional stability beyond viability metrics.
Freezing is a structural event. Structure determines function.
A Structural Shift in Cryobiology
Cryopreservation is evolving from temperature-based endpoints to structural phase-transition engineering.
As advanced cellular systems move toward clinical implementation, structural control during freezing becomes foundational.
Controlling structure means preserving function.
Structural Control as a Primary Variable
Traditional cryopreservation models prioritize cooling rates and terminal temperature endpoints.
Proton CryoTech introduces structural control of ice formation as a primary engineering variable.
TECHNOLOGY
PROTON Magnetic Freezing Technology was developed in Japan as an advanced approach to controlled freezing processes.
Its engineering foundation integrates electromagnetic field-assisted freezing to influence crystallization dynamics.
This structural approach laid the groundwork for its evolution toward biomedical contexts.
Structural Ice Control Technology
Engineering ice formation dynamics through controlled electromagnetic fields based on Japanese PROTON Magnetic Freezing Technology.
The Physics of Phase Transition
During freezing, biological systems undergo a phase transition where water forms ice crystals.
Crystal nucleation, growth rate, and spatial organization determine mechanical stress distribution within cells and tissues.
Temperature alone does not define structural outcome.
Crystallization dynamics do.
Electromagnetic Field Integration
PROTON technology introduces controlled electromagnetic fields during the freezing phase.
These fields influence nucleation behavior and contribute to a more structurally organized crystallization process.
The objective is modulation of ice formation dynamics rather than acceleration of temperature decline.
Proton CryoTech supports structural preservation across:
where PF-15 neo
fits in
Advanced Cellular Therapies
iPSC-derived platforms and regenerative workflows
Neurodegenerative Research
Dopaminergic progenitor research models
Biobanking
Long-term biological storage with structural focus
Fertility & Tissue Research
Sensitive biological material preservation
%20copia.avif)
Scientific evidence
Validation in Japan includes iPSC‑derived dopaminergic neurospheres (Parkinson model) showing preserved markers and functional readouts after cryopreservation.
What’s measured
Functional outcomes beyond viability: dopamine secretion, electrophysiological activity, and dopaminergic marker expression (e.g., TH, FOXA2, NURR1) in 3D neurosphere systems.
Why it matters
Many cryopreservation protocols keep cells “alive” but compromise structural integrity — resulting in lower function, inconsistent batches, and limited scalability for off‑the‑shelf therapies.
3D constructs
Designed to reduce the typical survival drop seen in aggregates, organoids, and tissues.
Reproducibility
Targets standardizable workflows compatible with high‑quality lab operations.
Safer logistics
Enables more flexible cold‑chain options, reducing operational dependency on LN₂ handling.
“In advanced therapies, the real success metric is not survival — it’s whether cells retain their intended biological function after thawing.”
Intellectual Property
& Technical
Documentation
PATENTS & TECHNICAL DOCUMENTATION
PROTON Magnetic Freezing Technology is supported by international patent documentation related to controlled freezing methodologies and structural preservation systems.
Technical publications and applied research contexts have explored the implications of structural ice modulation in biological environments.
Selected references and documentation are available upon institutional request.
Patent portfolio includes filings in Japan and Europe related to electromagnetic-assisted freezing control methodologies.
-
EP 4 063 496 A1 (Europa)
-
JP 2025094837 A (Japan)
-
US 2023000071 A1 (USA)
iPSC-Based
Therapeutic
Implementation
in Japan
iPSC CLINICAL CONTEXT IN JAPAN
Japan has led global development of induced pluripotent stem cell (iPSC)-based therapeutic programs, including dopaminergic progenitor platforms associated with Parkinson’s disease.
The transition of iPSC-derived systems into real clinical application underscores the importance of reliable cryopreservation methodologies capable of maintaining functional biological integrity.
As regenerative medicine advances toward scalable implementation, structural preservation at the moment of freezing becomes increasingly relevant.
Structural
Considerations
in Modern
Cryobiology
CRYOBIOLOGY CONTEXT
Cryobiology has historically emphasized temperature endpoints and storage stability. However, structural dynamics during phase transition play a critical role in determining biological outcomes.
Ice nucleation behavior, crystal growth kinetics, and mechanical stress distribution influence membrane integrity, intracellular architecture, and long-term functional stability.
Emerging research contexts increasingly highlight the importance of structural control during freezing rather than temperature reduction alone.
Resources
Executive summary, physical foundation of structural freezing, and clinical validation in iPSC-derived dopaminergic neurospheres (Japan).
Peer-reviewed publications, patent documentation (JP / EP / US), and structural cryobiology framework.
Institutional implementation model for PF-15 NEO in advanced therapy manufacturing and regenerative medicine programs.
